Abstract: A compound of the formula wherein the substituents are as defined in the specification and pharmaceutical salts thereof having a good affinity for sub-types of melanocortin receptors making them useful for treating diseases in which such receptors are included such as pain, inflammatory conditions, etc.
Type:
Grant
Filed:
February 25, 2004
Date of Patent:
April 8, 2008
Assignee:
Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)